ciprofloxacin hydrochloride and hydrocortisone

FDA Drug Profile — CIPRO HC, ciprofloxacin hydrochloride and hydrocortisone

Drug Details

Generic Name
ciprofloxacin hydrochloride and hydrocortisone
Brand Names
CIPRO HC, ciprofloxacin hydrochloride and hydrocortisone
Application Number
NDA020805
Sponsor
Asclemed USA, Inc.
NDC Codes
5
Dosage Forms
SUSPENSION/ DROPS
Routes
AURICULAR (OTIC)
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDE, HYDROCORTISONE

Indications and Usage

INDICATIONS AND USAGE CIPRO ® HC OTIC is indicated for the treatment of acute otitis externa in adult and pediatric patients, one year and older, due to susceptible strains of Pseudomonas aeruginosa , Staphylococcus aureus , and Proteus mirabilis .

Warnings

WARNINGS NOT FOR OPHTHALMIC USE. NOT FOR INJECTION. CIPRO ® HC OTIC should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolones. Serious acute hypersensitivity reactions may require immediate emergency treatment. The dropper cap contains natural rubber (latex) which may cause severe allergic reactions.